SC Proof of Efficacy Study
Research payments
$467,876
Through program year 2021, $467,876 in research payments was reported against SC Proof of Efficacy Study, across 57 payments.
- Paid by (largest first)
- Genentech, Inc.; Roche Products Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $1,500 | 1 |
| 2020 | Research | $182,531 | 24 |
| 2019 | Research | $283,845 | 32 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Phillip Green Portage, MI Named on 17 payments
- Mohammad Bolouri Charlotte, NC Named on 11 payments
- Jaron Winston Austin, TX Named on 8 payments
- Christopher Galloway Orlando, FL Named on 8 payments
- Herman Buschke Bronx, NY Named on 5 payments
- Lisa Catapano-Friedman Bennington, VT Named on 4 payments
- Nicholas Weber Orlando, FL Named on 3 payments
- Harvey Schwartz Hollywood, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.